#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Von Willebrand's disease Inclusion body myositis Frontotemporal dementia Lymphatic malformation Thrombocytopenia Partial lipodystrophy Gastrointestinal disorder Anti-myelin-associated glycoprotein associated polyneuropathy Ewing's sarcoma Paraneoplastic neurological syndrome Waldenstrom's macroglobulinaemia recurrent Prolymphocytic leukaemia Fibrous dysplasia of bone Acquired haemophilia Blastic plasmacytoid dendritic cell neoplasia More trials…

    Learn about Rare Diseases

    Pemphigus – Basic Information Atypical haemolytic uraemic syndrome – Treatment Hairy cell leukaemia – Diagnostics Congenital nephrogenic diabetes insipidus – Treatment Factor VIII deficiency – Life with Disease Amyotrophic lateral sclerosis – Treatment Anaplastic thyroid cancer – Life with Disease Basal cell naevus syndrome – Diagnostics Osteosarcoma metastatic – Basic Information Myxofibrosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zetomipzomib Palonosetron Zenocutuzumab Berubicin Hydrochloride VOXVOGANAN Bms-986315 Cangrelor Tetrasodium Surzebiclimab ALN-4324 Bicalutamide CEFTAROLINE FOSAMIL Ecoo1A Iph5201 Human Coagulation Factor Vii Diltiazem YL201 Masofaniten Ranitidine Hydrochloride Loperamide Hydrochloride Certolizumab Pegol More therapies…

    Learn about Your Condition

    Neuropathic arthropathy Necrotising myositis Hypochondroplasia Breast cancer Tuberculosis Lymphocytic leukaemia Neurogenic bladder Renal cancer recurrent Chronic spontaneous urticaria Chondrosarcoma Follicular lymphoma stage II Inner ear disorder Acute leukaemia Asthmatic crisis Post-traumatic stress disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study using MPPF imaging to examine serotonin pathways in the brainstem of patients with Dravet Syndrome epilepsy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Severe myoclonic epilepsy of infancy
    Investigated Drugs:
    • 4-Fluoro-N-[2-[4-(2-Methoxyphenyl)Piperazin-1-Yl]Ethyl]-N-Pyridin-2-Ylbenzamide
    France

  • Comparing Two Doses of Dexamethasone to Improve Quality of Life in Patients 60 Years and Older Having Total Hip Replacement Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hip arthroplasty
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    Belgium

  • Study of Switching from Intravenous to Oral Antibiotics in Patients with Infective Endocarditis Using a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocarditis
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • Benzylpenicillin Sodium
    • Clavulanic Acid
    Belgium

  • A Study Comparing Gadopiclenol and Gadoterate Meglumine for Heart MRI Scans in Children with Congenital Heart Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Meglumine Gadoterate
    Spain

  • A study testing semaglutide with counselling to reduce cravings and use of chemsex-related drugs in adults who use these substances

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Semaglutide
    Belgium

  • A Study Using [AL[18F]F]FAPI-74 PET Scan to Improve Diagnosis and Monitoring of Giant Cell Arteritis in Patients with This Blood Vessel Disease

    Recruiting

    4 1 1
    Investigated Diseases:
    • Giant cell arteritis
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Belgium
Previous Page
1 … 74 75 76 77 78 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!